Ameriprise’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.2M Buy
1,906,529
+87,288
+5% +$2.11M 0.01% 987
2026
Q1
$44M Buy
1,819,241
+99,072
+6% +$2.4M 0.01% 937
2025
Q4
$41.8M Buy
1,720,169
+113,496
+7% +$2.76M 0.01% 973
2025
Q3
$39.1M Buy
1,606,673
+104,787
+7% +$2.54M 0.01% 1027
2025
Q2
$36.4M Buy
1,501,886
+236,150
+19% +$5.7M 0.01% 1024
2025
Q1
$30.6M Sell
1,265,736
-287,480
-19% -$6.91M 0.01% 1077
2024
Q4
$37.2M Sell
1,553,216
-78,611
-5% -$1.89M 0.01% 996
2024
Q3
$39.9M Sell
1,631,827
-3,315,548
-67% -$79.9M 0.01% 950
2024
Q2
$117M Buy
4,947,375
+199,597
+4% +$4.72M 0.03% 459
2024
Q1
$113M Buy
4,747,778
+3,418,512
+257% +$81.4M 0.03% 491
2023
Q4
$31.7M Sell
1,329,266
-356,374
-21% -$8.32M 0.01% 1001
2023
Q3
$39M Sell
1,685,640
-67,835
-4% -$1.58M 0.01% 862
2023
Q2
$41.2M Buy
1,753,475
+194,989
+13% +$4.61M 0.01% 855
2023
Q1
$37.1M Buy
1,558,486
+591,449
+61% +$14M 0.01% 899
2022
Q4
$22.6M Buy
967,037
+233,266
+32% +$5.41M 0.01% 1153
2022
Q3
$16.9M Buy
733,771
+541,144
+281% +$12.9M 0.01% 1287
2022
Q2
$4.6M Buy
192,627
+5,019
+3% +$121K ﹤0.01% 2348
2022
Q1
$4.67M Buy
187,608
+10,670
+6% +$274K ﹤0.01% 2467
2021
Q4
$4.7M Sell
176,938
-10,001
-5% -$266K ﹤0.01% 2503
2021
Q3
$5.04M Sell
186,939
-501
-0.3% -$13.6K ﹤0.01% 2380
2021
Q2
$5.08M Sell
187,440
-7,833
-4% -$211K ﹤0.01% 2445
2021
Q1
$5.22M Buy
195,273
+7,907
+4% +$215K ﹤0.01% 2375
2020
Q4
$5.17M Buy
187,366
+3,204
+2% +$87.5K ﹤0.01% 2251
2020
Q3
$5M Buy
184,162
+7,127
+4% +$194K ﹤0.01% 2085
2020
Q2
$4.77M Buy
177,035
+3,564
+2% +$92.7K ﹤0.01% 2099
2020
Q1
$4.25M Buy
173,471
+56,533
+48% +$1.46M ﹤0.01% 2020
2019
Q4
$3.04M Buy
116,938
+23,668
+25% +$613K ﹤0.01% 2514
2019
Q3
$2.42M Buy
93,270
+73,523
+372% +$1.89M ﹤0.01% 2613
2019
Q2
$503K Buy
19,747
+7,621
+63% +$189K ﹤0.01% 3336
2019
Q1
$297K Buy
+12,126
New +$290K ﹤0.01% 3452

Other funds holding IBDS

Ameriprise's IBDS Position: Q2 2026 in Review

Ameriprise increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 4.8% in Q2 2026, buying an estimated $2.11M and bringing the position to 1,906,529 shares worth $46.2M. The position accounts for 0.01% of the portfolio, ranked #987.

Ameriprise first reported a position in IBDS in Q1 2019 and has held it in 30 quarters since. The position peaked at $117M in Q2 2024. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Ameriprise held 1,906,529 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $46.2M as of Q2 2026.
  • Ameriprise bought 87,288 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $2.11M.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.01% of Ameriprise's portfolio in Q2 2026, its #987 holding.
  • Ameriprise first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2019 and has held it in 30 quarters since.
  • Ameriprise's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $117M in Q2 2024.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.